Vascularized Fibular Graft for Persistent Humeral Nonunion
Finally, a solution after multiple revision surgeries for delayed bone healing, loose hardware and unrelenting infection
Related Articles
Excellent Long-Term Outcomes Achievable With Modified Aortic Reimplantation
Large analysis shows excellent survival and freedom from reintervention over 15 years following modified valve-sparing aortic reimplantation.
2024 Novel Drug and Biological Product Approvals
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B – MedCity News
Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will…
Head trauma & herpes, antidepressants & breast milk, Califf & Humpty Dumpty
Research links head trauma, herpes and Alzheimer’s, and STAT has a Q&A with outgoing FDA chief Robert Califf.
Erythritol’s Link to Heart Attack and Stroke
A popular sugar alcohol found in a range of diet and sugar-free foods has been linked to an increased risk for life-threatening heart conditions. Here’s…
Delta changed the game for CES press conferences
Airplane snacks? Flight simulators? Celebrities? Coffee smells? Indoor fireworks? A concert? Delta did that at Sphere for CES 2025.
To Connect With Customers, Get Personal, Use Empathy And Smart Tech
To connect with customers, particularly online, is a priority for many businesses. Here’s how and why you should get personal, use empathy and smart tech.
Lutetium 177 Radionuclide Therapy–Induced Proliferative Arrest in a Metastatic High-Grade Rectal Neuroendocrine Tumor
An adult man with low-volume liver metastases from grade 3 rectal neuroendocrine tumor (Ki67 index of 25%) sequentially underwent multiple systemic therapies. Gallium (88Ga)-DOTATATE scan…
Stryker strikes $4.9B deal to buy Inari Medical
Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at $4.9 billion.
Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.
